The effect of comorbidity on glycemic control and systolic blood pressure in type 2 diabetes: A cohort study with 5 year follow-up in primary care

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Luijks, Hilde ^a   Biermans, Marion ^a   Bor, Hans ^a   Van Weel, Chris ^a,b   Lagro Janssen, Toine ^a   De Grauw, Wim ^a   Schermer, Tjard ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DISEASE CONTROL; FEMALE; GLYCEMIC CONTROL; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MENTAL DISEASE; MUSCULOSKELETAL DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PRIMARY MEDICAL CARE; SEX DIFFERENCE; SOCIAL STATUS; SYSTOLIC BLOOD PRESSURE; BLOOD; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; FOLLOW UP; GLUCOSE BLOOD LEVEL; METABOLISM; PATHOPHYSIOLOGY; PRIMARY HEALTH CARE; STATISTICS AND NUMERICAL DATA;

ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; COHORT STUDIES; COMORBIDITY; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; PRIMARY HEALTH CARE;

EID: 84947253711     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0138662     Document Type: Article

References (44)

1. American Diabetes Association (2013) Standards of medical care in diabetes-2013. Diabetes Care 36 Suppl 1: S11-66. doi: 10.2337/dc13-S011 PMID: 23264422
2. Dutch College of General Practitioners (2013) Practice Guideline type 2 diabetes, 3rd revision. Huisarts Wet 56: 512-525.
3. Greenfield S, Billimek J, Pellegrini F, Franciosi M, DeBerardis G, et al. (2009) Comorbidity affects the relationship between glycemic control and cardiovascular outcomes in diabetes: a cohort study. Ann Intern Med 151: 854-860. doi: 10.7326/0003-4819-151-12-200912150-00005 PMID: 20008761
4. Van den Akker M, Buntinx F, Knottnerus J (1996) Comorbidity or multimorbidity: what's in a name? A review of literature. Eur J Gen Pract 2: 65-70.
5. Valderas JM, Starfield B, Sibbald B, Salisbury C, Roland M (2009) Defining comorbidity: implications for understanding health and health services. Ann Fam Med 7: 357-363. doi: 10.1370/afm.983 PMID: 19597174
6. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, et al. (2012) Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet 380: 37-43. doi: 10.1016/S0140-6736(12)60240-2 PMID: 22579043
7. Luijks H, Schermer T, Bor H, Van Weel C, Lagro-Janssen T, et al. (2012) Prevalence and incidence density rates of chronic comorbidity in type 2 diabetes patients: an exploratory cohort study. BMC Med 10:128. doi: 10.1186/1741-7015-10-128 PMID: 23106808
8. Caughey GE, Roughead EE, Vitry AI, McDermott RA, Shakib S, et al. (2010) Comorbidity in the elderly with diabetes: Identification of areas of potential treatment conflicts. Diabetes Res Clin Pract 87: 385-393. doi: 10.1016/j.diabres.2009.10.019 PMID: 19923032
9. Struijs JN, Baan CA, Schellevis FG, Westert GP, Van den Bos GA (2006) Comorbidity in patients with diabetes mellitus: impact on medical health care utilization. BMC Health Serv Res 6: 84. PMID: 16820048
10. Teljeur C, Smith SM, Paul G, Kelly A, O'DowdT (2013) Multimorbidity in a cohort of patients with type 2 diabetes. Eur J Gen Pract 19:17-22. doi: 10.3109/13814788.2012.714768 PMID: 23432037
11. France EF, Wyke S, Gunn JM, Mair FS, McLean G, et al. (2012) Multimorbidity in primary care: asys-tematic review of prospective cohort studies. Br J Gen Pract 62: e297-307. doi: 10.3399/bjgp12X636146 PMID: 22520918
12. Talley NJ, Young L, Bytzer P, Hammer J, Leemon M, et al. (2001) Impact of chronic gastrointestinal symptoms in diabetes mellitus on health-related quality of life. Am J Gastroenterol 96: 71-76. PMID: 11197290
13. Niefeld MR, Braunstein JB, Wu AW, Saudek CD, Weller WE, et al. (2003) Preventable hospitalization among elderly Medicare beneficiaries with type 2 diabetes. Diabetes Care 26:1344-1349. PMID: 12716786
14. Ashton CM, Septimus J, Petersen NJ, Souchek J, Menke TJ, et al. (2003) Healthcare use by veterans treated for diabetes mellitus in the Veterans Affairs medical care system. Am J Manag Care 9:145-150. PMID: 12597602
15. Peters SA, Huxley RR, Woodward M (2014) Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858, 507 individuals and 28, 203 coronary events. Diabetologia 57:1542-1551. doi: 10.1007/s00125-014-3260-6 PMID: 24859435
16. Grintsova O, Maier W, MielckA(2014) Inequalities in health care among patients with type 2 diabetes by individual socio-economic status (SES) and regional deprivation: a systematic literature review. Int J Equity Health 13: 43. doi: 10.1186/1475-9276-13-43 PMID: 24889694
17. Souto-Gallardo Mde L, Bacardi Gascon M, Jimenez Cruz A (2011) Effect of weight loss on metabolic control in people with type 2 diabetes mellitus: systematic review. Nutr Hosp 26:1242-1249. doi: 10.1590/S0212-16112011000600008 PMID: 22411367
18. Raz I, Riddle MC, Rosenstock J, Buse JB, Inzucchi SE, et al. (2013) Personalized management of hyperglycemia in type 2 diabetes: reflections from a Diabetes Care Editors' Expert Forum. Diabetes Care 36:1779-1788. doi: 10.2337/dc13-0512 PMID: 23704680
19. Lugtenberg M, Burgers JS, Clancy C, Westert GP, Schneider EC (2011) Current guidelines have limited applicability to patients with comorbid conditions: a systematic analysis of evidence-based guidelines. PLoS One 6: e25987. doi: 10.1371/journal.pone.0025987 PMID: 22028802
20. Kerr EA, Heisler M, Krein SL, Kabeto M, Langa KM, et al. (2007) Beyond comorbidity counts: how do comorbidity type and severity influence diabetes patients' treatment priorities and self-management? J Gen Intern Med 22:1635-1640. PMID: 17647065
21. Bayliss EA, Blatchford PJ, Newcomer SR, Steiner JF, Fairclough DL (2011) The effect of incident cancer, depression and pulmonary disease exacerbations on type 2 diabetes control. J Gen Intern Med 26: 575-581. doi: 10.1007/s11606-010-1600-x PMID: 21203859
22. Chaudhry SI, Berlowitz DR, Concato J (2005) Do age and comorbidity affect intensity of pharmacological therapy for poorly controlled diabetes mellitus? J Am GeriatrSoc 53: 1214-1216. PMID: 16108941
23. Woodard LD, Urech T, Landrum CR, Wang D, Petersen LA (2011) Impact of comorbidity type on measures of quality for diabetes care. Med Care 49: 605-610. doi: 10.1097/MLR.0b013e31820f0ed0 PMID: 21422952
24. Voorham J, Haaijer-Ruskamp FM, Wolffenbuttel BH, De Zeeuw D, Stolk RP, et al. (2012) Differential effects of comorbidity on antihypertensive and glucose-regulating treatment in diabetes mellitus-a cohort study. PLoS One 7: e38707. doi: 10.1371/journal.pone.0038707 PMID: 22679516
25. Roy T, Lloyd CE (2012) Epidemiology of depression and diabetes: a systematic review. J Affect Disord 142Suppl: S8-21. doi: 10.1016/S0165-0327(12)70004-6 PMID: 23062861
26. Van WeelC (2008) The Continuous Morbidity Registration Nijmegen: background and history of a Dutch general practice database. Eur J Gen Pract 14 Suppl 1: 5-12. doi: 10.1080/13814780802436028 PMID: 18949638
27. Van Weel C, Schers H, Timmermans A (2012) Health care in the Netherlands. J Am Board Fam Med 25 Suppl 1: S12-17. doi: 10.3122/jabfm.2012.02.110212 PMID: 22403245
28. Statistics Netherlands (2012): Statistics Netherlands.
29. Schers H, Bor H, Vanden Hoogen H, Van WeelC (2008) What went and what came? Morbidity trends in general practice from the Netherlands. Eur J Gen Pract 14 Suppl 1:13-24.
30. de Grauw WJ, van Gerwen WH, van de Lisdonk EH, van den Hoogen HJ, van den Bosch WJ, et al. (2002) Outcomes of audit-enhanced monitoring of patients with type 2 diabetes. J Fam Pract 51: 459-464. PMID: 12019056
31. (2014) www.cckl.nl.
32. Bentsen BG (1986) International classification of primary care. Scand J Prim Health Care 4: 43-50. PMID: 3961309
33. Piette JD, Kerr EA (2006) The impact of comorbid chronic conditions on diabetes care. Diabetes Care 29: 725-731. PMID: 16505540
34. Luijks H, De Grauw W, Bor H, Van Weel C, Lagro-Janssen T, et al. (2015) Exploring the impact of chronic obstructive pulmonary disease (COPD) on diabetes control in diabetes patients: a prospective observational study in general practice. npj Prim Care Respir Med 25. doi: 10.1038/npjpcrm.2015.32 PMID: 25906025
35. Twisk JWR (2003) Applied longitudinal data analysis for epidemiology: Cambridge University Press. 301 p.
36. Dutch College of General Practitioners (2006) Practice guideline type 2 diabetes, 2nd revision. Huisarts Wet 49:137-152.
37. Van Weel-Baumgarten EM, Van den Bosch WJ, Van den Hoogen HJ, Zitman FG (2000) The validity of the diagnosis of depression in general practice: is using criteria for diagnosis as a routine the answer? Br J Gen Pract 50: 284-287. PMID: 10897511
38. Van Weel C (1995) Validating long term morbidity recording. J Epidemiol Community Health 49: 29-32. PMID: 7561667
39. Klein Woolthuis EP, De Grauw WJ, Van Gerwen WH, Van den Hoogen HJ, Van de Lisdonk EH, et al. (2009) Yield of opportunistic targeted screening for type 2 diabetes in primary care: the diabscreen study. Ann Fam Med 7: 422-430. doi: 10.1370/afm.997 PMID: 19752470
40. Pyorala K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, et al. (1997) Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care 20: 614-620. PMID: 9096989
41. Sinnott C, Mc Hugh S, Browne J, Bradley C (2013) GPs' perspectives on the management of patients with multimorbidity: systematic review and synthesis of qualitative research. BMJ Open 3: e003610. doi: 10.1136/bmjopen-2013-003610 PMID: 24038011
42. Luijks HD, Loeffen MJ, Lagro-Janssen AL, Van Weel C, Lucassen PL, et al. (2012) GPs' considerations in multimorbidity management: a qualitative study. Br J Gen Pract 62: e503-510. doi: 10.3399/bjgp12X652373 PMID: 22781998
43. UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphony-lureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352: 837-853. PMID:9742976
44. Olde Hartman TC, Lucassen PL, Van de Lisdonk EH, Bor HH, Van Weel C (2004) Chronicfunctional somatic symptoms: a single syndrome? Br J Gen Pract 54: 922-927. PMID: 15588538